Article Text

Download PDFPDF
Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity
  1. K Gecse1,
  2. R Róka2,
  3. L Ferrier1,
  4. M Leveque1,
  5. H Eutamene1,
  6. C Cartier1,
  7. A Ait-Belgnaoui1,
  8. A Rosztóczy2,
  9. F Izbéki2,
  10. J Fioramonti1,
  11. T Wittmann2,
  12. L Bueno1
  1. 1 Neuro-Gastroenterology and Nutrition Unit, INRA Toulouse, France
  2. 2 First Department of Internal Medicine, University of Szeged, Szeged, Hungary
  1. Dr L Bueno, Neuro-Gastroenterology and Nutrition Unit, Institut National de la Recherche Agronomique, 180 Chemin de Tournefeuille, BP 3, 31931 Toulouse Cedex 9, France; lbueno{at}


Objectives: Diarrhoea-predominant irritable bowel syndrome (IBS-D) is characterised by elevated colonic lumenal serine protease activity. The aims of this study were (1) to investigate the origin of this elevated serine protease activity, (2) to evaluate if it may be sufficient to trigger alterations in colonic paracellular permeability (CPP) and sensitivity, and (3) to examine the role of the proteinase-activated receptor-2 (PAR-2) activation and signalling cascade in this process.

Patients and methods: Faecal enzymatic activities were assayed in healthy subjects and patients with IBS, ulcerative colitis and acute infectious diarrhoea. Following mucosal exposure to supernatants from control subjects and IBS-D patients, electromyographic response to colorectal balloon distension was recorded in wild-type and PAR-2–/– mice, and CPP was evaluated on colonic strips in Ussing chambers. Zonula occludens-1 (ZO-1) and phosphorylated myosin light chain were detected by immunohistochemistry.

Results: The threefold increase in faecal serine protease activity seen in IBS-D patients compared with constipation-predominant IBS (IBS-C) or infectious diarrhoea is of neither epithelial nor inflammatory cell origin, nor is it coupled with antiprotease activity of endogenous origin. Mucosal application of faecal supernatants from IBS-D patients in mice evoked allodynia and increased CPP by 92%, both of which effects were prevented by serine protease inhibitors and dependent on PAR-2 expression. In mice, colonic exposure to supernatants from IBS-D patients resulted in a rapid increase in the phosphorylation of myosin light chain and delayed redistribution of ZO-1 in colonocytes.

Conclusions: Elevated colonic lumenal serine protease activity of IBS-D patients evokes a PAR-2-mediated colonic epithelial barrier dysfunction and subsequent allodynia in mice, suggesting a novel organic background in the pathogenesis of IBS.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: None.

  • Funding: KG is a recipient of a postdoctoral fellowship from INRA. This work was supported by an institutional grant from INRA.

  • Patient consent: All subjects provided written and informed consent to participate.

  • Ethics approval: The study protocol was approved by the Ethical Committee of the University of Szeged. The animal experimental protocols were approved by the local Institutional Animal Care and Use Committee.

Linked Articles